Latest Articles
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance
Published: Sept. 6, 2025, 11:31 a.m.
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - Medical Xpress
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Medical Xpress
Published: Sept. 5, 2025, 4:10 p.m.
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer - News-Medical
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer News-Medical
Published: Sept. 5, 2025, 4 a.m.
New Radiotheranostic Targets Discovered for Enhanced Diagnosis and Treatment of Endometrial Cancer - BIOENGINEER.ORG
New Radiotheranostic Targets Discovered for Enhanced Diagnosis and Treatment of Endometrial Cancer BIOENGINEER.ORG
Published: Sept. 4, 2025, 9:37 p.m.
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - EurekAlert!
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer EurekAlert!
Published: Sept. 4, 2025, 9:25 p.m.
Closing Deadly Gaps in Endometrial Cancer Care Outcomes - Medscape
Closing Deadly Gaps in Endometrial Cancer Care Outcomes Medscape
Published: Sept. 4, 2025, 1:52 p.m.
Johor Hospital completes first robotic surgery for endometrial cancer - MSN
Johor Hospital completes first robotic surgery for endometrial cancer MSN
Published: Sept. 4, 2025, 1:14 p.m.
Age, Race Play a Role in Endometrial Cancer Outcomes - Cancer Nursing Today
Age, Race Play a Role in Endometrial Cancer Outcomes Cancer Nursing Today
Published: Sept. 3, 2025, 11:02 p.m.
XPR1: Emerging Prognostic Marker in Endometrial Cancer - BIOENGINEER.ORG
XPR1: Emerging Prognostic Marker in Endometrial Cancer BIOENGINEER.ORG
Published: Sept. 2, 2025, 9:51 a.m.
Lactate-Induced M2 Macrophages Boost Endometrial Cancer Progression - BIOENGINEER.ORG
Lactate-Induced M2 Macrophages Boost Endometrial Cancer Progression BIOENGINEER.ORG
Published: Aug. 29, 2025, 10:40 p.m.
Link copied to clipboard!